Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08SWN
|
|||
Former ID |
DNC014471
|
|||
Drug Name |
(+/-)-threo-3',5'-Dimethylmethylphenidate
|
|||
Synonyms |
CHEMBL1253692; BDBM50327134
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H23NO2
|
|||
Canonical SMILES |
CC1=CC(=CC(=C1)C(C2CCCCN2)C(=O)OC)C
|
|||
InChI |
1S/C16H23NO2/c1-11-8-12(2)10-13(9-11)15(16(18)19-3)14-6-4-5-7-17-14/h8-10,14-15,17H,4-7H2,1-3H3/t14-,15-/m1/s1
|
|||
InChIKey |
OQNVWHLLYQJVEV-HUUCEWRRSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
KEGG Pathway | Dopaminergic synapse | |||
Parkinson's disease | ||||
Cocaine addiction | ||||
Amphetamine addiction | ||||
Alcoholism | ||||
Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
Parkinson disease | ||||
Dopamine receptor mediated signaling pathway | ||||
Pathway Interaction Database | Alpha-synuclein signaling | |||
Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
WikiPathways | Monoamine Transport | |||
NRF2 pathway | ||||
Dopaminergic Neurogenesis | ||||
Parkinsons Disease Pathway | ||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
Neurotransmitter Clearance In The Synaptic Cleft |
References | Top | |||
---|---|---|---|---|
REF 1 | Quantitative structure-activity relationship studies of threo-methylphenidate analogs. Bioorg Med Chem. 2010 Oct 15;18(20):7221-38. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.